Cardiovascular disease (CVD) is the number one killer of women globally. Urgent global action is required to improve the screening, diagnosis and treatment journey for women with cardiovascular disease. That’s why Global Heart Hub hosted a patient-led roundtable on late, missed and misdiagnosis of heart disease in women in Madrid, Spain, bringing together 27 participants from across 15 countries, including women with lived experience, patient organisation leaders, public health experts, researchers and clinicians.

The one-day international roundtable discussion, in collaboration with the Global Heart Hub Women & Heart Disease Working Group, focused on the issues of under-representation of women in clinical trials, late, missed and misdiagnosis of heart disease in women, under-research of female-specific risk factors and heart conditions.

The resulting report focuses on four priority areas:

• Healthcare system and medical education;
• Research;
• Patient & public engagement and awareness;
• Policy change and public health.

These priority areas provide a roadmap for Global Heart Hub as it embarks on a journey to engage with relevant stakeholders, with the aim to improve the screening, diagnosis and treatment journey for women with cardiovascular disease.

Read the report now: Global Heart Hub International Roundtable Discussion on Late, Missed and Misdiagnosis of Heart Disease in Women

#WomenandCVD #TakeAction #WomenandHeart